Medicine and Dentistry
Glioblastoma
100%
Patient
53%
Implant
50%
Dosimetry
50%
Analysis
50%
Magnetic Resonance Imaging
50%
Brachytherapy
50%
Differentiation
50%
6 O Methylguanine
50%
Heterozygosity
50%
Biological Marker
50%
DNA Methyltransferase
50%
Isocitrate Dehydrogenase 1
50%
Diagnosis
40%
Gland
37%
Promoter Region
33%
Edema
25%
Multiple Linear Regression Analysis
25%
Ganglioglioma
21%
Age Groups
16%
Specimen
16%
Molecular Marker
16%
Marker
16%
Side Effect
14%
Dose Calculation
12%
Dose-Volume Histogram
12%
X-Ray Imaging
12%
Magnetic Resonance Imaging
12%
Therapeutic Procedure
7%
Neoplasm
7%
Adverse Event
7%
Neuroscience
Glioblastoma Multiforme
66%
Brain
50%
Metastasis
50%
6-O-Methylguanine
50%
Glioma
25%
Chemotherapy
7%
Biochemistry, Genetics and Molecular Biology
O-6-Methylguanine-DNA Methyltransferase
50%
Loss of Heterozygosity
50%
Isocitrate Dehydrogenase
50%
Prospective Study
25%
Molecular Biology
16%
Genetic Marker
16%
Phase II Trials
12%
Clinical Trial
12%
Phase I Trials
12%
